It’s True Trump Paid Stormy Daniels Himself, But Congress

New Post Public Reply Private Reply Replies (0) Message Board
Lmcat
101
It’s True Trump Paid Stormy Daniels Himself, But Congress Desperate To Hide The Fact They Paid Victims $17 Million W/ OUR Money …

Which is Worse?

Representative Jerry Nadler seemed to put the Democrats’ reaction to Michael Cohen’s plea of “guilty” and his actions against the President perfectly into a fairly simple explanation.

There has been talk for a while now that the New York Democrat has been toying with the idea of impeachment hearings against President Donald Trump and his people, no matter what the evidence involves.

A day after the midterm elections, a report was released which Conservative Tribune says “had the powerful ranking member of the House Judiciary Committee ranting on a train about impeaching Supreme Court Justice Brett Kavanaugh. He also talked about going ‘all in’ on Russia.”

This weekend, Nadler appeared on CNN to talk about Michael Cohen’s claim that the President had told him to pay porn star Stormy Daniels as a part of a “non-disclosure” agreement. He then claimed that Trump had paid him back. Nadler stated that this would be enough to have Trump removed from his post as President.

“They would be impeachable offenses. Whether they’re important enough to justify an impeachment is a different question,” Nadler said while on CNN.

“Certainly, they’re impeachable offenses, because, even though they were committed before the president became president, they were committed in the service of fraudulently obtaining the office,” he continued.

In the past, Nadler has called President Trump “non legitimate” as a President of the United States. The mainstream media is eating it up, but they’re not remembering the campaign finance issues at hand. And, there’s also the question of whether or not this counts as campaign finance.

And can Congress really talk?

Thebradfordfile tweeted, “Is Congress going to release the names of everyone in Congress who has been implicated in a sexual harassment claim which was kept silent by a taxpayer funded shush fund—before or after they try to impeach President Trump for using his own money for something perfectly legal?”

Is Congress going to release the names of everyone in Congress who has been implicated in a sexual harassment claim which was kept silent by a taxpayer funded shush fund–before or after they try to impeach President Trump for using his own money for something perfectly legal?

— thebradfordfile™ (@thebradfordfile) December 10, 2018

Conservative Tribune writes:

Yes, $17 million of taxpayer money has been spent on settling, among other things, sexual harassment claims in Congress, and we pretty much don’t know anything about the cases. As CNN noted, the names of those involved are withheld not only from the public but also from party leadership.

“A source in House Speaker Paul Ryan’s office told CNN that Ryan is not made aware of the details of harassment settlements.

That source also said that the top Democrat and Republican on the House administration committee review proposed settlements and both must approve the payments,” CNN reported in November of 2017. “Similarly, a source in Minority Leader Nancy Pelosi’s office told CNN that Pelosi also is not made aware of those details, and that they are confined to the parties of the settlement and the leaders of the administration committee.”

Think about it… this is the way the establishment set up the system so they don’t have to deal with the repercussions of sexual harassment lawsuits and discrimination lawsuits… because they KNEW there would be so many.

Interesting how Trump paid a much smaller amount of money to a woman who he had consensual sex with to get an NDA.

Conservative Tribune explains:

Because of the methodology of obtaining it and the question of whether or not it should have been included in campaign finance reports, we’re now talking impeachment.

Apparently, Nadler isn’t going all-in on Russia, he’s going all-in on Stormy. I guess it’s easier.

So, yes, Nadler can continue to claim that “the president was at the center of a massive fraud — several massive frauds against the American people.” That doesn’t actually mean anything. If we scrutinized the campaign ledgers of everyone in high office for any sort of problem, we’d probably have to extirpate at least half of them from their position.

Now, here’s the thing: I haven’t seen the Mueller report. Neither has Nadler. For all I know, Trump is implicated in a panoply of heinous crimes and his ties with Russia were way more extensive than we thought. Or it could be a very big nothingburger, albeit a nothingburger dressed up like a very appetizing somethingburger and advertised incessantly in the media like it was the Arch Deluxe circa 1992.

“You don’t necessarily launch an impeachment against the president because he committed an impeachable offense,” Nadler said. “There are several things you have to look at.”

“One, were impeachable offenses committed, how many, et cetera. Secondly, how important were they? Do they rise to the gravity where you should undertake an impeachment?

An impeachment is an attempt to effect or overturn the result of the last election and should do it only for very serious situations. That’s the question.”

https://www.americanjournalreview.com/its-tru...-is-worse/


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading